Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-01-20 Sale | 2026-01-22 5:24 pm | NewAmsterdam Pharma Co N.V. | NAMS | Somaiya Mayur Ian Chief Financial Officer | 100,000 | $32.61 | $3,260,618 | 1,423,794 (Direct) | View |
| 2026-01-05 Sale | 2026-01-07 6:27 pm | NewAmsterdam Pharma Co N.V. | NAMS | Somaiya Mayur Ian Chief Financial Officer | 5,118 | $33.25 | $170,174 | 173,382 (Direct) | View |
| 2025-01-27 Sale | 2025-01-29 5:25 pm | NewAmsterdam Pharma Co N.V. | NAMS | Somaiya Mayur Ian Chief Financial Officer | 61,883 | $0 | $0 | 1,578,528 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-01-20 Exercise | 2026-01-22 5:24 pm | N/A 2033-11-01 | NewAmsterdam Pharma Co N.V. | NAMS | Somaiya Mayur Ian Chief Financial Officer | 100,000 | $0 | 1,423,794 (Direct) | View |
| 2026-01-20 Exercise | 2026-01-22 5:24 pm | N/A N/A | NewAmsterdam Pharma Co N.V. | NAMS | Somaiya Mayur Ian Chief Financial Officer | 100,000 | $9.26 | 1,423,794 (Direct) | View |
| 2026-01-07 Option Award | 2026-01-07 6:27 pm | N/A 2036-01-07 | NewAmsterdam Pharma Co N.V. | NAMS | Somaiya Mayur Ian Chief Financial Officer | 140,500 | $0 | 173,382 (Direct) | View |
| 2025-01-27 Exercise | 2025-01-29 5:25 pm | N/A 2033-11-01 | NewAmsterdam Pharma Co N.V. | NAMS | Somaiya Mayur Ian Chief Financial Officer | 61,883 | $0 | 1,578,528 (Direct) | View |
| 2025-01-27 Exercise | 2025-01-29 5:25 pm | N/A N/A | NewAmsterdam Pharma Co N.V. | NAMS | Somaiya Mayur Ian Chief Financial Officer | 61,883 | $9.26 | 1,578,528 (Direct) | View |
| 2025-01-07 Option Award | 2025-01-07 5:08 pm | N/A N/A | NewAmsterdam Pharma Co N.V. | NAMS | Somaiya Mayur Ian Chief Financial Officer | 38,000 | $0 | 38,000 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 5:53 pm | N/A 2035-01-02 | NewAmsterdam Pharma Co N.V. | NAMS | Somaiya Mayur Ian Chief Financial Officer | 220,000 | $0 | 220,000 (Direct) | View |
| 2024-01-01 Option Award | 2024-01-03 5:10 pm | N/A 2034-01-01 | NewAmsterdam Pharma Co N.V. | NAMS | Somaiya Mayur Ian Chief Financial Officer | 80,000 | $0 | 80,000 (Direct) | View |
Ownership | 2023-12-29 4:30 pm | N/A 2033-11-01 | NewAmsterdam Pharma Co N.V. | NAMS | Somaiya Mayur Ian Chief Financial Officer | 0 | $0 | 824,697 (Direct) | View |